Microsoft Corp said on Monday it would buy some of the assets of Rosetta Biosoftware, part of a Merck & Co Inc unit which makes data management software for medical researchers, furthering Microsoft's push into the expanding healthcare technology business
Friday, June 5, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment